
<!doctype html><html lang="en"> <head><meta charset="utf-8"> 
<title>s800 inconsistencies</title> 
<style>

.gray { background-color:rgba(125, 125, 125, 0.5); } 
.orange { background-color:rgba(210, 180, 180, 0.5); } 

.match { text-decoration: underline; 
/*
  -webkit-text-decoration-color: red;  
  text-decoration-color: red; */
    -webkit-text-decoration-line: overline underline; /* Safari */
   text-decoration-line: overline underline; 
   color:yellow;
/*   font-weight:bold; */
  
  
  } 
.LINNAEUS_only { background-color: rgba(125, 125, 125, 0.5); }
.annotated { background-color:rgba(50, 180, 180, 0.5); } 
.unannotated { background-color:rgba(214, 75, 79, 0.5); } 

.match_species { text-decoration: underline; } 
/*
ul#menu li {
/*  display:inline; 
}
.horizontal { display: inline; border-left: 3px solid darkorange; padding-left: 0.3em; }
.first { border-left: none; padding-left: 0; }
*/
ul#menu li {
list-style-type: circle;
}
table { border-collapse: collapse; } 
th, td { border: 1px solid orange; padding: 4px; } 
th {  cursor: pointer; } 
th:hover { background: yellow; }

html, body, iframe { height: 100%; }

* {
  box-sizing: border-box;
}

.row {
  display: flex;
}


/* Create two equal columns that sits next to each other */
.column {
  flex: 50%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column1 {
  flex: 30%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column2 {
  flex: 70%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
 
</style></head><body>
<h2>20980506</h2><span class="unannotated">not annotated</span> - <span class="annotated">annotated</span> - <span class="LINNAEUS_only">LINNAEUS only</span><br><hr>A new model of <span class="annotated ">Epstein-Barr virus</span> infection reveals an important role for earlylytic <span class="unannotated ">viral</span> protein expression in the development of lymphomas.<br><br><span class="annotated ">Epstein-Barr virus</span> (<span class="annotated ">EBV</span>) infects cells in latent or lytic forms, but the roleof lytic infection in <span class="annotated ">EBV</span>-induced lymphomas is unclear. Here, we have used anew humanized <span class="annotated ">mouse</span> model, in which both <span class="annotated ">human</span> fetal CD34(+) hematopoietic stemcells and thymus/liver tissue are transplanted, to compare <span class="annotated ">EBV</span> pathogenesis andlymphoma formation following infection with a lytic replication-defectiveBZLF1-deleted (Z-KO) <span class="unannotated ">virus</span> or a lytically active BZLF1(+) control. Both thecontrol and Z-KO viruses established long-term <span class="unannotated ">viral</span> latency in all infectedanimals. The infection appeared well controlled in some animals, but otherseventually developed CD20(+) diffuse large B cell lymphomas (DLBCL). Animalsinfected with the control <span class="unannotated ">virus</span> developed tumors more frequently than Z-KOvirus-infected animals. Specific immune responses against <span class="annotated ">EBV</span>-infected B cellswere generated in <span class="annotated ">mice</span> infected with either the control <span class="unannotated ">virus</span> or the Z-KOvirus. In both cases, forms of <span class="unannotated ">viral</span> latency (type I and type IIB) wereobserved that are less immunogenic than the highly transforming form (type III)commonly found in tumors of immunocompromised hosts, suggesting that immunepressure contributed to the outcome of the infection. These results point to animportant role for lytic <span class="annotated ">EBV</span> infection in the development of B cell lymphomasin the context of an active host immune response.
<br><br><br><hr><h3>Ann file</h3><pre>T1	Species 15 33	Epstein-Barr virus<br><br>N1	Reference T1 Taxonomy:10376<br><br>T2	Species 144 162	Epstein-Barr virus<br><br>N2	Reference T2 Taxonomy:10376<br><br>T3	Species 164 167	EBV<br><br>N3	Reference T3 Taxonomy:10376<br><br>T4	Species 243 246	EBV<br><br>N4	Reference T4 Taxonomy:10376<br><br>T5	Species 311 316	mouse<br><br>N5	Reference T5 Taxonomy:10090<br><br>T6	Species 338 343	human<br><br>N6	Reference T6 Taxonomy:9606<br><br>T7	Species 435 438	EBV<br><br>N7	Reference T7 Taxonomy:10376<br><br>T8	Species 962 965	EBV<br><br>N8	Reference T8 Taxonomy:10376<br><br>T9	Species 1000 1004	mice<br><br>N9	Reference T9 Taxonomy:10090<br><br>T10	Species 1384 1387	EBV<br><br>N10	Reference T10 Taxonomy:10376<br><br></pre></body></html>